Skip to main content

Published since 1929, this monthly journal reports current research in all aspects of physiology, nutrition, pharmacology, and toxicology, contributed by recognized experts and scientists. It publishes symposium reviews and award lectures and occasionally dedicates entire issues or portions of issues to subjects of special interest to its international readership.

Publisher: NRC Research Press

More about this publication?
Volume 80, Number 5, May 2002

Preface / Préface
pp. ii-ii(1)

Favourites:
ADD

NMR studies of CCK-8/CCK1 complex support membrane-associated pathway for ligand-receptor interaction
pp. 383-387(5)
Authors: Giragossian, C.; Pellegrini, M.; Mierke, D.F.

Favourites:
ADD

Melanin-concentrating hormone and its receptors: state of the art
pp. 388-395(8)
Authors: Boutin, J.A.; Suply, T.; Audinot, V.; Rodriguez, M.; Beauverger, P.; Nicolas, J-P.; Galizzi, J-P.; Fauchère, J-L.

Favourites:
ADD

Peptide signals regulating food intake and energy homeostasis
pp. 396-406(11)
Authors: Blevins, J.E.; Schwartz, M.W.; Baskin, D.G.

Favourites:
ADD

Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors
pp. 407-412(6)
Authors: Bigoni, R.; Calò, G.; Rizzi, A.; Okawa, H.; Regoli, D.; Smart, D.; Lambert, D.G.

Favourites:
ADD

Interaction of a non-peptide agonist with angiotensin II AT1 receptor mutants
pp. 413-417(5)
Authors: Costa-Neto, C.M.; Miyakawa, A.A.; Pesquero, J.B.; Oliveira, L.; Hjorth, S.A.; Schwartz, T.W.; Paiva, A.C.

Favourites:
ADD

Angiotensin II is bound to both receptors AT1 and AT2, parallel to the transmembrane domains and in an extended form
pp. 418-425(8)
Authors: Escher, E.; Deraët, M.; Rihakova, L.; Boucard, A.; Pérodin, J.; Sauvé, S.; Mathieu, A.P.; Guillemette, G.; Leduc, R.; Lavigne, P.

Favourites:
ADD

Relevant role of Leu265 in helix VI of the angiotensin AT1 receptor in agonist binding and activity
pp. 426-430(5)
Authors: Correa, S.A.A.; França, L.P.; Costa-Neto, C.M.; Oliveira, L.; Paiva, A.C.M.; Shimuta, S.I.

Favourites:
ADD

Nonpeptidic endothelin-converting enzyme inhibitors and their potential therapeutic applications
pp. 440-449(10)
Authors: Jeng, A.Y.; Mulder, P.; Kwan, A-L.; Battistini, B.

Favourites:
ADD
Favourites:
ADD

Dipeptide sulfonamides as endothelin ETA/ETB receptor antagonists
pp. 464-469(6)
Authors: Jeng, A.Y.; Ksander, G.M.; Shetty, S.S.; DelGrande, D.; Balwierczak, J.L.; Bruseo, C.W.; Savage, P.; deJesus, R.; Yuan, A.; Webb, R.L.

Favourites:
ADD
Favourites:
ADD

Biochemical and pharmacological activities of SSR 146977, a new potent nonpeptide tachykinin NK3 receptor antagonist
pp. 482-488(7)
Authors: Poncelet, M.; Emonds-Alt, X.; Vilain, P.; Proietto, V.; Fur, G.L.; Steinberg, R.; Maffrand, J-P.; Advenier, C.; Soubrié, P.; Daoui, S.; Pascal, M.; Naline, E.; Gueudet, C.; Michaud, J-C.; Oury-Donat, F.

Favourites:
ADD

Regulation of nociceptive neurons by nerve growth factor and glial cell line derived neurotrophic factor
pp. 495-505(11)
Authors: Priestley, J.V.; Michael, G.J.; Averill, S.; Liu, M.; Willmott, N.

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more